Medeva Overview
- Year Founded
-
1987

- Status
-
Acquired/Merged
- Employees
-
2,372

- Latest Deal Type
-
M&A
- Financing Rounds
-
2
- Investments
-
3
Medeva General Information
Description
Manufacturer of pharmaceutical products intended to help treat patients suffering from severe diseases. The company specializes in the research, development and commercialization of pharmaceutical and biotechnology products in the fields of the central nervous system, allergy, respiratory, immune disorders and oncology, enabling medical researchers to quickly discover medicines to treat patients and their families.
Contact Information
Website
www.medeva.co.ukCorporate Office
- 10 St James's Street
- London SW1A 1EF
- England, United Kingdom
Corporate Office
- 10 St James's Street
- London SW1A 1EF
- England, United Kingdom
Medeva Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Medeva Patents
Medeva Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
GB-9720033-D0 | Hepatitis b virus polypeptides | Inactive | 19-Sep-1997 | ||
GB-9504265-D0 | Corticosteroid-containing pharmaceutical composition | Pending | 03-Mar-1995 | ||
JP-H11501045-A | Corticosteroid-containing drug composition | Active | 03-Mar-1995 | ||
EP-0813413-A1 | Corticosteroid-containing pharmaceutical composition | Active | 03-Mar-1995 | ||
EP-0813413-B1 | Corticosteroid-containing foam | Inactive | 03-Mar-1995 | A61K31/573 |
Medeva Signals
Medeva Acquisitions (3)
Medeva’s most recent deal was a Merger/Acquisition with Tillotts Pharma for . The deal was made on 01-Nov-1995.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Tillotts Pharma | 01-Nov-1995 | Merger/Acquisition | Pharmaceuticals | ||
ribosepharm | 01-Apr-1993 | Merger/Acquisition | Distributors (Healthcare) | ||
Armstrong Pharmaceuticals | 14-Jan-1993 | Merger/Acquisition | Discovery Tools (Healthcare) |
Medeva Exits (3)
Medeva’s most recent exit was on 01-Nov-1995 from Tillotts Pharma. The exit was categorized as .
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
Tillotts Pharma | 01-Nov-1995 | Completed |
|
||
ribosepharm | 01-Apr-1993 | Completed |
|
||
Armstrong Pharmaceuticals | 14-Jan-1993 | Merger/Acquisition | Completed |
Medeva Affiliates
Subsidiaries (1)
Name | Industry | Location | Year Founded |
---|---|---|---|
Celltech | Slough, United Kingdom | 1980 |
Medeva FAQs
-
When was Medeva founded?
Medeva was founded in 1987.
-
Where is Medeva headquartered?
Medeva is headquartered in London, United Kingdom.
-
What is the size of Medeva?
Medeva has 2,372 total employees.
-
What industry is Medeva in?
Medeva’s primary industry is Biotechnology.
-
Is Medeva a private or public company?
Medeva is a Private company.
-
What is the current valuation of Medeva?
The current valuation of Medeva is
. -
What is Medeva’s current revenue?
The current revenue for Medeva is
. -
When was Medeva acquired?
Medeva was acquired on 25-Jan-2000.
-
Who acquired Medeva?
Medeva was acquired by Celltech Chiroscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »